{"id":277686,"date":"2022-10-19T12:50:31","date_gmt":"2022-10-19T17:50:31","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=277686"},"modified":"2022-10-19T12:50:31","modified_gmt":"2022-10-19T17:50:31","slug":"trial-fda-approval-extend-abortion-pill-gestation","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/","title":{"rendered":"New trial seeks FDA approval for extending abortion pill use later in gestation"},"content":{"rendered":"<div style=\"margin-top: 0px; margin-bottom: 0px;\" class=\"sharethis-inline-share-buttons\" ><\/div><p>Chemically ending the lives of <a href=\"https:\/\/archive.liveaction.org\/news\/guttmacher-abortion-spike-2020-pregnancies\/\" target=\"_blank\" rel=\"noopener\">over 500,000 preborn babies<\/a> yearly with the abortion pill (5 million <a href=\"https:\/\/archive.liveaction.org\/news\/data-abortion-pill-ended-5-million-babies\/\" target=\"_blank\" rel=\"noopener\">since<\/a> its approval in 2000) is a staggering and sobering number \u2014 and\u00a0thanks to pro-abortion groups like Gynuity Health Projects (GHP), this number is likely to increase.<\/p>\n<p>The abortion pill regimen, which consists of mifepristone (RU-486) and misoprostol, is currently only FDA-<a href=\"https:\/\/archive.liveaction.org\/news\/abortion-pill-dangerous-safety-requirement\/\" target=\"_blank\" rel=\"noopener\">approved<\/a> through 70 days (10 weeks) gestation. But, as Live Action News has reported, the industry is already <a href=\"https:\/\/archive.liveaction.org\/news\/reports-abortion-pill-kill-babies-late-pregnancy\/\" target=\"_blank\" rel=\"noopener\">committing abortions<\/a> well past this timeframe, flouting FDA&#8217;s guidelines. Now, Gynuity is testing\u00a0the <a href=\"https:\/\/archive.liveaction.org\/news\/abortion-pill-21-years-secrecy-death\/\" target=\"_blank\" rel=\"noopener\">abortion pill<\/a>\u00a0for Food and Drug Administration (FDA) approval up to 84 days or <strong>12 weeks<\/strong> \u2014 a point at which\u00a0the preborn child&#8217;s bones are beginning to calcify (harden), and when studies <a href=\"https:\/\/archive.liveaction.org\/news\/preborn-children-feel-pain-8-weeks\/\" target=\"_blank\" rel=\"noopener\">indicate<\/a> that the child has the capacity to feel pain.<\/p>\n<p><strong>Even Planned Parenthood admits how developed a baby is at this stage<\/strong><\/p>\n<p>Women who use abortion pills to end their pregnancies could potentially\u00a0<a href=\"https:\/\/archive.liveaction.org\/news\/abortion-industry-destigmatize-option-seeing-remains\/\" target=\"_blank\" rel=\"noopener\">see the remains<\/a> of their babies once\u00a0<a href=\"https:\/\/archive.liveaction.org\/news\/abortion-pill-trauma-pain\/\" target=\"_blank\" rel=\"noopener\">expelled into a toilet<\/a>.\u00a0Between 11 and 12 weeks, the <a href=\"https:\/\/babyolivia.liveaction.org\/share\/\" target=\"_blank\" rel=\"noopener\">preborn child<\/a> can play in the womb and her taste buds have matured into discrete tastebuds, according to Live Action&#8217;s <a href=\"https:\/\/babyolivia.liveaction.org\/share\/\" target=\"_blank\" rel=\"noopener\">Baby Olivia website<\/a>.<\/p>\n<p style=\"text-align: center;\"><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/cpdY97GOK2I\" width=\"640\" height=\"355\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe>\n<\/p>\n<p>Even Planned Parenthood acknowledges\u00a0that at this point in gestation, &#8220;Fingers and toes grow longer. The umbilical cord connects the abdomen of the fetus to the placenta. The placenta is attached to the wall of the uterus and it absorbs nutrients from the bloodstream. The cord carries nutrients and oxygen to the fetus and takes waste away from the fetus.&#8221; Planned Parenthood also notes, &#8220;Fingers and toes are no longer webbed. Bones begin hardening. Skin and fingernails begin to grow. Changes triggered by hormones begin to make external sex organs appear \u2014 female or male. The fetus begins making spontaneous movements. Kidneys start making urine. Early sweat glands appear. Eyelids are fused together.&#8221;<\/p>\n<p><b>URGENT:\u00a0<\/b><a href=\"https:\/\/give.liveaction.org\/future-of-abortion\/?utm_source=lan&amp;utm_medium=article&amp;utm_campaign=minibomb\"><b><i>For every dollar given, 34 more people can be reached with the truth about abortion. Will you join us in this life-saving work as a monthly donor today?<\/i><\/b><\/a><\/p>\n<div id=\"attachment_277692\" style=\"width: 945px\" class=\"wp-caption aligncenter\"><img aria-describedby=\"caption-attachment-277692\" decoding=\"async\" loading=\"lazy\" class=\"size-full wp-image-277692\" src=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Planned-Parenthood-fetal-development-9-10-weeks-and-11-12-weeks-accessed-10112022.jpg\" alt=\"Image: Planned Parenthood fetal development 9-10 weeks and 11-12 weeks accessed 10112022\" width=\"935\" height=\"633\" srcset=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Planned-Parenthood-fetal-development-9-10-weeks-and-11-12-weeks-accessed-10112022.jpg 935w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Planned-Parenthood-fetal-development-9-10-weeks-and-11-12-weeks-accessed-10112022-300x203.jpg 300w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Planned-Parenthood-fetal-development-9-10-weeks-and-11-12-weeks-accessed-10112022-768x520.jpg 768w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Planned-Parenthood-fetal-development-9-10-weeks-and-11-12-weeks-accessed-10112022-700x474.jpg 700w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Planned-Parenthood-fetal-development-9-10-weeks-and-11-12-weeks-accessed-10112022-500x339.jpg 500w\" sizes=\"(max-width: 935px) 100vw, 935px\" \/><p id=\"caption-attachment-277692\" class=\"wp-caption-text\">Planned Parenthood fetal development 9-10 weeks and 11-12 weeks (accessed 10\/11\/2022)<\/p><\/div>\n<p><strong>Goal of Gynuity abortion pill study is solely to expand the pill&#8217;s use later in pregnancy<\/strong><\/p>\n<p>In an e-mail to supporters, Gynuity wrote that it &#8220;has initiated a study to strengthen the evidence for extending the gestational age limit for outpatient medication abortion beyond 70 days of pregnancy\u2014the current limit set by the U.S. Food and Drug Administration. This latest in a trilogy of studies will explore with more rigor an adjustment to the dosing regimen in the later first trimester (11 and 12 weeks of pregnancy).&#8221;<\/p>\n<div id=\"attachment_248914\" style=\"width: 603px\" class=\"wp-caption aligncenter\"><img aria-describedby=\"caption-attachment-248914\" decoding=\"async\" loading=\"lazy\" class=\"size-large wp-image-248914\" src=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2021\/07\/10-week-preborn-child-in-womb-593x700.jpg\" alt=\"\" width=\"593\" height=\"700\" srcset=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2021\/07\/10-week-preborn-child-in-womb-593x700.jpg 593w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2021\/07\/10-week-preborn-child-in-womb-254x300.jpg 254w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2021\/07\/10-week-preborn-child-in-womb-768x907.jpg 768w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2021\/07\/10-week-preborn-child-in-womb-500x591.jpg 500w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2021\/07\/10-week-preborn-child-in-womb.jpg 1000w\" sizes=\"(max-width: 593px) 100vw, 593px\" \/><p id=\"caption-attachment-248914\" class=\"wp-caption-text\">10 weeks from fertilization (12 weeks gestation\/LMP)<\/p><\/div>\n<p>A search at the FDA&#8217;s Clinical Trial website <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05119439?term=Gynuity%2C+Philadelphia+Women%E2%80%99s+Center&amp;draw=2&amp;rank=2\" target=\"_blank\" rel=\"noopener\">reveals<\/a> that a trial entitled, &#8220;An Outpatient Medical Abortion Regimen With Mifepristone and Two Doses of Misoprostol at 71-77 and 78-84 Days of Pregnancy,&#8221;\u00a0has not yet begun to recruit but is shockingly seeking participants ranging anywhere from ages <strong>11<\/strong> to 55.<\/p>\n<p>The trial seeks to &#8220;evaluate the efficacy, side effect profile and acceptability of a medical abortion regimen with mifepristone and two doses of 800 mcg misoprostol buccally at 71-77 and 78-84 days of gestation to further expand the evidence base for the most effective regimens in the late first trimester of pregnancy.&#8221;<\/p>\n<div id=\"attachment_277766\" style=\"width: 1869px\" class=\"wp-caption aligncenter\"><img aria-describedby=\"caption-attachment-277766\" decoding=\"async\" loading=\"lazy\" class=\"wp-image-277766 size-full\" src=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Gynuity-abortion-pill-clinical-trail-for-use-through-twelve-weeks-of-pregnancy.jpg\" alt=\"Image: Gynuity abortion pill clinical trial for use through twelve weeks of pregnancy\" width=\"1859\" height=\"1043\" srcset=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Gynuity-abortion-pill-clinical-trail-for-use-through-twelve-weeks-of-pregnancy.jpg 1859w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Gynuity-abortion-pill-clinical-trail-for-use-through-twelve-weeks-of-pregnancy-300x168.jpg 300w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Gynuity-abortion-pill-clinical-trail-for-use-through-twelve-weeks-of-pregnancy-768x431.jpg 768w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Gynuity-abortion-pill-clinical-trail-for-use-through-twelve-weeks-of-pregnancy-700x393.jpg 700w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Gynuity-abortion-pill-clinical-trail-for-use-through-twelve-weeks-of-pregnancy-500x281.jpg 500w\" sizes=\"(max-width: 1859px) 100vw, 1859px\" \/><p id=\"caption-attachment-277766\" class=\"wp-caption-text\">Gynuity abortion pill clinical trial for use through twelve weeks of pregnancy<\/p><\/div>\n<p>According to GHP&#8217;s announcement, the trial will take place at the following locations:<\/p>\n<ul>\n<li>Planned Parenthood Great Northwest, Hawai&#8217;i, Alaska, Indiana, Kentucky (PPGNHAIK);<\/li>\n<li>Philadelphia Women\u2019s Center;<\/li>\n<li>Planned Parenthood North Central States (PPNCS); and the<\/li>\n<li>Queen&#8217;s Medical Center (Hawaii).<\/li>\n<\/ul>\n<p>&#8220;An additional two clinics\u2014one in Tennessee and the other in Georgia\u2014had to withdraw from the study due to the enforcement of post-Roe abortion bans in their states,&#8221; Gynuity also wrote. Those included\u00a0CHOICES Memphis\u00a0Center for Reproductive Health as well as the\u00a0Atlanta\u00a0Women&#8217;s Center.<\/p>\n<p><strong>Previous trials<\/strong><\/p>\n<p>&#8220;This new study builds on our two published studies evaluating the success of combined mifepristone-misoprostol regimens for abortion through the 11th week of pregnancy,&#8221; Gynuity wrote in their e-mail.<\/p>\n<p style=\"padding-left: 30px;\"><em>The\u00a0<a href=\"https:\/\/r20.rs6.net\/tn.jsp?f=001Am9F9zzvIBONV-Gqp4Ej1H_SHihWDH1ovOpboBVBwpmoxguBEipWFHqfeWX02kI1G3HXbmanl0h1rji73K8hRfCJJdRM5yxIvRa8cBxjtnGCSdxobzy3uhjIVsP-6t0BWlfUsSPxecIi9OhMzPP2JaqG6lalk4sDl1khjomWdHfurvLZDiQJV9g5gDnMhErm1a6RtXCnkfTvbbtBDI7YWsxEzPJhGB0IFnogbkypkhclX4tVHvYLsU8FP8LguP0oAJjCXhejilt-ZvbbChXSlyDBZWM4y7WPmuOzvnyU08VCmB6-ue9MRh4xmP1MzSaG&amp;c=t0QDLZAB7QHOqWcSq0XZkYsBHrs-k4QHEcOZeXBstDMF9C2fZmQ_2A==&amp;ch=TaQEwMG4iutOznS2sXW-NEUCtIOHioPh59DVqbSQjlOCB70d0HyLTw==\" target=\"_blank\" rel=\"noopener\">first study<\/a>\u00a0prospectively assessed the efficacy of a common first trimester outpatient regimen using one dose of mifepristone 200mg and one dose of misoprostol 800mcg. Our findings demonstrated a particularly good chance of abortion success: 92.3% and 86.7% in the 10th and 11th week, respectively. Ongoing pregnancy was 3.6% and 8.7%, respectively. This regimen could be a reasonable option for medication abortion at 11 weeks, <strong>but the findings indicated that the significant increase in continuing pregnancies in the later week was cause for concern. <\/strong>[emphasis added].<\/em><\/p>\n<p style=\"padding-left: 30px;\"><em>The\u00a0<a href=\"https:\/\/r20.rs6.net\/tn.jsp?f=001Am9F9zzvIBONV-Gqp4Ej1H_SHihWDH1ovOpboBVBwpmoxguBEipWFLIHTzsPUd8xls5c5gXxD75vc_nlC5CNC5X0tygFvSNiigQDFnXA5xijY-mE2rv_aY6UMC7XpDNlMxLMglu-JWZHnBJ0ryICrNQDp9yzCujeyasi0G8MMpNbFnHUHcZ_mzaVv2TBrVGJ_T9Pwo_8KipytoIMiOUhdTMKAS7IqNXIGxBYW4HWInxGXLrOK23v0nHPD118P7j21qA_R0j1HPLLQ5z1Gt54vwxJrbogljo0cSslCB8OCwj50wtC92iXDbWku_5c8kSP_VU4X6rjGXjz9bBbwoCDgbea3sMBqpBCzwu1IRgfQdU=&amp;c=t0QDLZAB7QHOqWcSq0XZkYsBHrs-k4QHEcOZeXBstDMF9C2fZmQ_2A==&amp;ch=TaQEwMG4iutOznS2sXW-NEUCtIOHioPh59DVqbSQjlOCB70d0HyLTw==\" target=\"_blank\" rel=\"noopener\">second study<\/a>, a retrospective chart review, compared the regimen effectiveness of outpatient medication abortion at 10- and 11-weeks\u2019 gestation using a second 800mcg dose of misoprostol, four hours after the first one, following a 200mg dose of mifepristone taken up to 48 hours earlier. Findings showed that treatment success was seemingly higher (99.6% and 97.7% in the 10th and 11th weeks, respectively) and ongoing pregnancy was much lower (0.4% and 1.4%, respectively) than what we had observed in the first study. A quarter of clients did not return to the clinic for follow up, making it difficult to draw definitive conclusions about the efficacy of the study regimen. The regimen, however, showed promised and warranted more rigorous investigation.<\/em><\/p>\n<p>While GHP is touting the results as good, the reality is that the <a href=\"https:\/\/archive.liveaction.org\/news\/planned-parenthood-abortion-pill-fda-limit-failing\/\" target=\"_blank\" rel=\"noopener\">failure rate<\/a> of the abortion pill regimen at these later stages is abysmal.\u00a0Let&#8217;s do the math (10-11 weeks) using the\u00a0<a href=\"https:\/\/archive.liveaction.org\/news\/guttmacher-abortion-spike-2020-pregnancies\/\" target=\"_blank\" rel=\"noopener\">data above from the first study in 2020<\/a>, which showed that over 500,000 (502,286)\u00a0women used the abortion pill that year:<\/p>\n<ul>\n<li>The figure of 92.3% means that nearly 8% of women \u2014 over 40,000 \u2014 could experience an incomplete abortion (GHP claimed 3.6% actually had an ongoing pregnancy).<\/li>\n<li>The figure of 86.7% means that a whopping 13.3% of women \u2014 nearly 67,000 \u2014\u00a0could experience an incomplete abortion, (GHP claimed 8.47% had an ongoing pregnancy).<\/li>\n<\/ul>\n<p>While the added dose of misoprostol in the second study showed improvement, the conclusions\u00a0<a href=\"https:\/\/gynuity.org\/resources\/a-repeat-dose-of-misoprostol-800mcg-following-mifepristone-for-outpatient-medical-abortion-at-64-70-and-71-77-days-of-gestation-a-retrospective-chart-review\" target=\"_blank\" rel=\"noopener\">revealed<\/a> that &#8220;nearly 25% of clients were lost to follow up,&#8221; indicating that the .4% to 1.4% ongoing pregnancy results could be skewed. But, even if we were to believe that the figures were accurate, that still translates to 2000-7000+ women suffering incomplete abortions every year.<\/p>\n<p><strong>Who is Gynuity Health Projects (GHP)?<\/strong><\/p>\n<p>Gynuity\u2019s founder and president Beverly Winikoff will serve as the principal investigator of the upcoming trial. Winikoff serves on the <a href=\"https:\/\/prochoice.org\/about\/annual-reports\/2020-annual-report\/\" target=\"_blank\" rel=\"noopener\">board<\/a>\u00a0of the National Abortion Federation (NAF), which is\u00a0funded by the\u00a0<a href=\"https:\/\/www.grantmakers.io\/profiles\/v0\/476032365-susan-thompson-buffett-foundation\/?query=national%20abortion%20\" target=\"_blank\" rel=\"noopener\">Buffett<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.packard.org\/grants-and-investments\/grants-database\/national-abortion-federation-3\/\" target=\"_blank\" rel=\"noopener\">Packard<\/a>\u00a0Foundations, organizations which were early <a href=\"https:\/\/gynuity.org\/annual-reports\/2021\/supporters\" target=\"_blank\" rel=\"noopener\">investors<\/a>\u00a0of abortion pill manufacturer Danco Laboratories. NAF was also at one time directly\u00a0<a href=\"https:\/\/web.archive.org\/web\/20051003195946\/http:\/\/www.prochoice.org\/pubs_research\/publications\/downloads\/about_naf\/annual_report_2001.pdf\" target=\"_blank\" rel=\"noopener\">funded<\/a>\u00a0by Danco.<\/p>\n<p>Winikoff previously served on the\u00a0<a href=\"https:\/\/www.societyfp.org\/_documents\/annual_report2014.pdf\" target=\"_blank\" rel=\"noopener\">board<\/a>\u00a0of the Society of Family Planning (SFP). The group&#8217;s funding arm, the Society of Family Planning Research Fund (SFRF), originally created by the SFP Board in\u00a0<a href=\"https:\/\/www.contraceptionjournal.org\/article\/S0010-7824(15)30069-X\/fulltext\" target=\"_blank\" rel=\"noopener\">2011<\/a>, provided a grant for the clinical trial. Live Action News <a href=\"https:\/\/archive.liveaction.org\/news\/follow-money-pro-abortion-group-suicide-risk\/\" target=\"_blank\" rel=\"noopener\">previously<\/a> noted that SFP was\u00a0<a href=\"https:\/\/www.contraceptionjournal.org\/article\/S0010-7824(15)30069-X\/pdf\" target=\"_blank\" rel=\"noopener\">founded<\/a>\u00a0in 2005 with a generous contribution from the Packard Foundation and\u00a0<a href=\"http:\/\/990s.foundationcenter.org\/990pf_pdf_archive\/476\/476032365\/476032365_201612_990PF.pdf\" target=\"_blank\" rel=\"noopener\">receives<\/a>\u00a0millions from the Buffett Foundation.\u00a0Over past years, <a href=\"https:\/\/archive.liveaction.org\/news\/billionaires-behind-abortion-wealthy-population-control\/\" target=\"_blank\" rel=\"noopener\">abortion philanthropist<\/a> and abortion pill investor the Buffett Foundation has <a href=\"https:\/\/www.grantmakers.io\/profiles\/v0\/476032365-susan-thompson-buffett-foundation\/?query=society&amp;grantee_name=SOCIETY%20OF%20FAMILY%20PLANNING\" target=\"_blank\" rel=\"noopener\">poured<\/a>\u00a0over $15.3 million into SFP.<\/p>\n<p>The\u00a0<a href=\"https:\/\/www.grantmakers.io\/profiles\/v0\/476032365-susan-thompson-buffett-foundation\/?query=gynuity\" target=\"_blank\" rel=\"noopener\">Buffett<\/a>\u00a0and Packard Foundations also\u00a0<a href=\"https:\/\/gynuity.org\/donors\" target=\"_blank\" rel=\"noopener\">fund<\/a>\u00a0Gynuity, financing\u00a0<a href=\"https:\/\/archive.liveaction.org\/news\/study-funded-abortion-pill-investor-buffett-foundation\/\" target=\"_blank\" rel=\"noopener\">studies<\/a>\u00a0which are used to convince the public that abortion is safe.<\/p>\n<div id=\"attachment_277767\" style=\"width: 825px\" class=\"wp-caption aligncenter\"><img aria-describedby=\"caption-attachment-277767\" decoding=\"async\" loading=\"lazy\" class=\" wp-image-277767\" src=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Society-of-Family-Planning-funded-by-Danco-investor-Buffett-Foundation-per-Grantmakers.jpg\" alt=\"Image: Society of Family Planning (SFP) funded by Danco investor Buffett Foundation per Grantmakers\" width=\"815\" height=\"521\" srcset=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Society-of-Family-Planning-funded-by-Danco-investor-Buffett-Foundation-per-Grantmakers.jpg 1385w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Society-of-Family-Planning-funded-by-Danco-investor-Buffett-Foundation-per-Grantmakers-300x192.jpg 300w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Society-of-Family-Planning-funded-by-Danco-investor-Buffett-Foundation-per-Grantmakers-768x491.jpg 768w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Society-of-Family-Planning-funded-by-Danco-investor-Buffett-Foundation-per-Grantmakers-700x447.jpg 700w, https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/Society-of-Family-Planning-funded-by-Danco-investor-Buffett-Foundation-per-Grantmakers-500x319.jpg 500w\" sizes=\"(max-width: 815px) 100vw, 815px\" \/><p id=\"caption-attachment-277767\" class=\"wp-caption-text\">Society of Family Planning (SFP) funded by Danco investor Buffett Foundation per Grantmakers<\/p><\/div>\n<p>Winikoff previously worked with the Population Council in the original <a href=\"https:\/\/archive.liveaction.org\/news\/connection-abortion-pill-zyklonb-gas-holocaust\/\" target=\"_blank\" rel=\"noopener\">RU-486 abortion pill<\/a> trials. In recounting her role in the FDA\u00a0<a href=\"https:\/\/archive.liveaction.org\/news\/abortion-pill-secrecy-women-deserve-truth\/\" target=\"_blank\" rel=\"noopener\">approval of the drug<\/a>, Winikoff shockingly\u00a0<a href=\"https:\/\/archive.liveaction.org\/news\/abortion-pill-secrecy-women-deserve-truth\/\" target=\"_blank\" rel=\"noopener\">credited<\/a>\u00a0the 9\/11 terrorist attacks with saving the abortion pill by drowning out the news of a woman\u2019s abortion pill death. This response indicates that expanding access to the abortion pill has long been the goal of people like Winikoff.<\/p>\n<p>Will women&#8217;s safety again be put on the back burner in favor of increasing abortion access? Time (and trial) will tell.<\/p>\n<p><a href=\"https:\/\/pledge.liveaction.org\/?utm_source=lan&amp;utm_medium=email&amp;utm_campaign=prolife_pledge\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter size-large wp-image-277267\" src=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/pledge-live-action-ad-970x250-700x180.jpg\" alt=\"\" width=\"700\" height=\"180\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chemically ending the lives of over 500,000 preborn babies yearly with the abortion pill (5 million since its approval in 2000) is a staggering and sobering number \u2014 and\u00a0thanks to pro-abortion groups like Gynuity Health Projects (GHP), this number is likely to increase. The abortion pill regimen, which consists of mifepristone (RU-486) and misoprostol, is [&hellip;]<\/p>\n","protected":false},"author":303,"featured_media":278128,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false},"categories":[9953],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>New trial seeks FDA approval for extending abortion pill use later in gestation<\/title>\n<meta name=\"description\" content=\"The trial seeks participants aged 11 to 55, and seeks to expand use to 11-12 weeks, when a preborn child can feel pain and his or her bones begin to harden.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New trial seeks FDA approval for extending abortion pill use later in gestation\" \/>\n<meta property=\"og:description\" content=\"The trial seeks participants aged 11 to 55, and seeks to expand use to 11-12 weeks, when a preborn child can feel pain and his or her bones begin to harden.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/\" \/>\n<meta property=\"og:site_name\" content=\"Live Action News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/liveaction\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-19T17:50:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/10-weeks-fertilization-12-weeks-gestation.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Carole Novielli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/CaroleNovielli\" \/>\n<meta name=\"twitter:site\" content=\"@liveaction\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carole Novielli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/\"},\"author\":{\"name\":\"Carole Novielli\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/81ff4ca810d98b0b5b376a640452d9e6\"},\"headline\":\"New trial seeks FDA approval for extending abortion pill use later in gestation\",\"datePublished\":\"2022-10-19T17:50:31+00:00\",\"dateModified\":\"2022-10-19T17:50:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/\"},\"wordCount\":1310,\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"articleSection\":[\"Abortion Pill\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/\",\"name\":\"New trial seeks FDA approval for extending abortion pill use later in gestation\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\"},\"datePublished\":\"2022-10-19T17:50:31+00:00\",\"dateModified\":\"2022-10-19T17:50:31+00:00\",\"description\":\"The trial seeks participants aged 11 to 55, and seeks to expand use to 11-12 weeks, when a preborn child can feel pain and his or her bones begin to harden.\",\"breadcrumb\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/archive.liveaction.org\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New trial seeks FDA approval for extending abortion pill use later in gestation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"name\":\"Live Action News\",\"description\":\"Covering Human Rights, Abortion, &amp; Pro-Life Issues\",\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\",\"name\":\"Live Action\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"contentUrl\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"width\":701,\"height\":710,\"caption\":\"Live Action\"},\"image\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/liveaction\",\"https:\/\/twitter.com\/liveaction\",\"https:\/\/www.instagram.com\/liveactionorg\/\",\"https:\/\/www.pinterest.com\/LiveActionFilms\/\",\"https:\/\/www.youtube.com\/user\/LiveActionFilms\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/81ff4ca810d98b0b5b376a640452d9e6\",\"name\":\"Carole Novielli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/df095be9fa34b48e50413a07102ab289?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/df095be9fa34b48e50413a07102ab289?s=96&d=mm&r=g\",\"caption\":\"Carole Novielli\"},\"description\":\"Carole Novielli has over thirty years of research experience on abortion, Planned Parenthood and eugenics. Her work has been published by many reputable media outlets. As a woman opposed to abortion, Carole is a committed Christian who refuses to be silenced by the main stream media and the nation's pro-abortion feminist minority.\",\"sameAs\":[\"https:\/\/twitter.com\/https:\/\/twitter.com\/CaroleNovielli\"],\"url\":\"https:\/\/archive.liveaction.org\/news\/author\/carole\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New trial seeks FDA approval for extending abortion pill use later in gestation","description":"The trial seeks participants aged 11 to 55, and seeks to expand use to 11-12 weeks, when a preborn child can feel pain and his or her bones begin to harden.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/","og_locale":"en_US","og_type":"article","og_title":"New trial seeks FDA approval for extending abortion pill use later in gestation","og_description":"The trial seeks participants aged 11 to 55, and seeks to expand use to 11-12 weeks, when a preborn child can feel pain and his or her bones begin to harden.","og_url":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/","og_site_name":"Live Action News","article_publisher":"https:\/\/www.facebook.com\/liveaction","article_published_time":"2022-10-19T17:50:31+00:00","og_image":[{"width":1200,"height":650,"url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/10\/10-weeks-fertilization-12-weeks-gestation.jpg","type":"image\/jpeg"}],"author":"Carole Novielli","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/CaroleNovielli","twitter_site":"@liveaction","twitter_misc":{"Written by":"Carole Novielli","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/#article","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/"},"author":{"name":"Carole Novielli","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/81ff4ca810d98b0b5b376a640452d9e6"},"headline":"New trial seeks FDA approval for extending abortion pill use later in gestation","datePublished":"2022-10-19T17:50:31+00:00","dateModified":"2022-10-19T17:50:31+00:00","mainEntityOfPage":{"@id":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/"},"wordCount":1310,"publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"articleSection":["Abortion Pill"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/","url":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/","name":"New trial seeks FDA approval for extending abortion pill use later in gestation","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/#website"},"datePublished":"2022-10-19T17:50:31+00:00","dateModified":"2022-10-19T17:50:31+00:00","description":"The trial seeks participants aged 11 to 55, and seeks to expand use to 11-12 weeks, when a preborn child can feel pain and his or her bones begin to harden.","breadcrumb":{"@id":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/archive.liveaction.org\/news\/trial-fda-approval-extend-abortion-pill-gestation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/archive.liveaction.org\/news\/"},{"@type":"ListItem","position":2,"name":"New trial seeks FDA approval for extending abortion pill use later in gestation"}]},{"@type":"WebSite","@id":"https:\/\/archive.liveaction.org\/news\/#website","url":"https:\/\/archive.liveaction.org\/news\/","name":"Live Action News","description":"Covering Human Rights, Abortion, &amp; Pro-Life Issues","publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/archive.liveaction.org\/news\/#organization","name":"Live Action","url":"https:\/\/archive.liveaction.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","contentUrl":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","width":701,"height":710,"caption":"Live Action"},"image":{"@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/liveaction","https:\/\/twitter.com\/liveaction","https:\/\/www.instagram.com\/liveactionorg\/","https:\/\/www.pinterest.com\/LiveActionFilms\/","https:\/\/www.youtube.com\/user\/LiveActionFilms"]},{"@type":"Person","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/81ff4ca810d98b0b5b376a640452d9e6","name":"Carole Novielli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/df095be9fa34b48e50413a07102ab289?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df095be9fa34b48e50413a07102ab289?s=96&d=mm&r=g","caption":"Carole Novielli"},"description":"Carole Novielli has over thirty years of research experience on abortion, Planned Parenthood and eugenics. Her work has been published by many reputable media outlets. As a woman opposed to abortion, Carole is a committed Christian who refuses to be silenced by the main stream media and the nation's pro-abortion feminist minority.","sameAs":["https:\/\/twitter.com\/https:\/\/twitter.com\/CaroleNovielli"],"url":"https:\/\/archive.liveaction.org\/news\/author\/carole\/"}]}},"_links":{"self":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/277686"}],"collection":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/users\/303"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/comments?post=277686"}],"version-history":[{"count":31,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/277686\/revisions"}],"predecessor-version":[{"id":278531,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/277686\/revisions\/278531"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media\/278128"}],"wp:attachment":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media?parent=277686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/categories?post=277686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/tags?post=277686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}